Biogen Inc. (BIIB)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

Annual Data

Quarterly Data

Biogen Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Current portion of notes payable and other financing arrangements
Taxes payable
Accounts payable
Current portion of contingent consideration obligations
Revenue-related reserves for discounts and allowances
Employee compensation and benefits
Royalties and licensing fees
Collaboration expenses
Construction in progress
Accrued TECFIDERA litigation settlement charges
Other
Accrued expenses and other	%	%	%	%	%
Current liabilities	%	%	%	%	%
Notes payable and other financing arrangements, excluding current portion
Deferred tax liability
Other long-term liabilities
Non-current liabilities	%	%	%	%	%
Total liabilities	%	%	%	%	%
Preferred stock, par value $0.001 per share
Common stock, par value $0.0005 per share
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Treasury stock, at cost
Total Biogen Inc. shareholders' equity	%	%	%	%	%
Noncontrolling interests
Total equity	%	%	%	%	%
Total liabilities and equity	%	%	%	%	%

	Biogen Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality